Synonyms: RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin)
dalfopristin is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Dalfopristin is a semi-synthetic derivative of pristinamycin IIA (streptogramin A). It inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit. It is administered intravenously.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1999)) |
International Nonproprietary Names | |
INN number | INN |
6581 | dalfopristin |
Synonyms |
RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin) |
Database Links | |
Specialist databases | |
Antibiotic DB | Dalfopristin | Quinupristin/dalfopristin (Synercid) |
Other databases | |
CAS Registry No. | 112362-50-2 (source: WHO INN record) |
GtoPdb PubChem SID | 405560238 |
PubChem CID | 6323289 |
RCSB PDB Ligand | DOL |
Search Google for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |
Search Google for chemicals with the same backbone | SUYRLXYYZQTJHF |
Search PubMed clinical trials | dalfopristin |
Search PubMed titles | dalfopristin |
Search PubMed titles/abstracts | dalfopristin |
UniChem Compound Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |